checkAd

    TransCannaHoldings auf dem Weg zu einem leader? - Älteste Beiträge zuerst (Seite 218)

    eröffnet am 17.02.19 12:30:19 von
    neuester Beitrag 27.01.24 09:07:15 von
    Beiträge: 6.890
    ID: 1.298.502
    Aufrufe heute: 4
    Gesamt: 879.016
    Aktive User: 0

    ISIN: CA89356V1040 · WKN: A2PA4W · Symbol: TH8
    0,0070
     
    EUR
    0,00 %
    0,0000 EUR
    Letzter Kurs 06.04.23 Tradegate

    Werte aus der Branche Pharmaindustrie

    WertpapierKursPerf. %
    0,5700+55,23
    5,4500+41,56
    150,47+38,68
    1,0000+33,33
    6,5900+31,80
    WertpapierKursPerf. %
    0,7300-19,34
    20,000-20,00
    19,000-20,17
    18,280-21,55
    1,5100-24,12

     Durchsuchen
    • 1
    • 218
    • 689

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 23.08.19 12:02:02
      !
      Dieser Beitrag wurde von MODelfin moderiert. Grund: Tatsachenbehauptung ohne Beleg
      Avatar
      schrieb am 23.08.19 16:20:36
      Beitrag Nr. 2.172 ()
      boah, TC fällt ja immer noch... hat das denn nie ein Ende???
      TransCanna Holdings | 0,520 €
      3 Antworten?Die Baumansicht ist in diesem Thread nicht möglich.
      Avatar
      schrieb am 23.08.19 18:40:17
      Beitrag Nr. 2.173 ()
      Antwort auf Beitrag Nr.: 61.328.623 von Jet-Stream am 23.08.19 16:20:36
      Zitat von Jet-Stream: boah, TC fällt ja immer noch... hat das denn nie ein Ende???


      Das nimmt erst ein Ende, wenn die Firma nach Abzug aller Kosten schwarze Zahlen erwirtschaftet.

      In der Cannabis-Branche wimmelt es nur so von Firmen, die immer noch auf Genehmigungen warten oder irgendwelche Hallen bauen und dabei Massen an Geld verbrennen.
      Die steigen alle nicht.
      TransCanna Holdings | 0,500 €
      Avatar
      schrieb am 26.08.19 08:52:09
      Beitrag Nr. 2.174 ()
      Antwort auf Beitrag Nr.: 61.328.623 von Jet-Stream am 23.08.19 16:20:36Mehr als 50 Cent wird sie nicht mehr fallen
      TransCanna Holdings | 0,499 €
      1 Antwort?Die Baumansicht ist in diesem Thread nicht möglich.
      Avatar
      schrieb am 26.08.19 17:32:40
      Beitrag Nr. 2.175 ()
      Man kann sagen das die Aktie Ihren Weg geht...😂
      TransCanna Holdings | 0,476 €

      Trading Spotlight

      Anzeige
      InnoCan Pharma
      0,2280EUR +8,57 %
      Unfassbare Studie – LPT-Therapie bewahrt Patient vor dem Tod!mehr zur Aktie »
      Avatar
      schrieb am 26.08.19 17:47:57
      Beitrag Nr. 2.176 ()
      Vllt lohnt es sich bei 0,10€ einzusteigen und dann auf ein kurzen Hype zu hoffen der Gewinn bringt.
      TransCanna Holdings | 0,476 €
      1 Antwort?Die Baumansicht ist in diesem Thread nicht möglich.
      Avatar
      schrieb am 26.08.19 18:49:26
      Beitrag Nr. 2.177 ()
      Antwort auf Beitrag Nr.: 61.344.718 von Eisenfaust369 am 26.08.19 17:47:57Wäre mir zu riskant. Sind immer noch 10 Cent bis null.
      TransCanna Holdings | 0,455 €
      Avatar
      schrieb am 26.08.19 19:12:25
      Beitrag Nr. 2.178 ()
      Antwort auf Beitrag Nr.: 61.340.068 von beton0815 am 26.08.19 08:52:09
      Zitat von beton0815: Mehr als 50 Cent wird sie nicht mehr fallen


      qed
      TransCanna Holdings | 0,455 €
      Avatar
      schrieb am 26.08.19 20:06:07
      Beitrag Nr. 2.179 ()
      Da werden noch viele billig ausgegebene Warrents in kommender Zeit fällig, mit denen andere beazhlt wurden, z.B. Adveetisment,,,, und denen ist es egal was sie dafür bekommen ,,, bei Warrents von 0,10 cent ,,, wird eine Flut ausgelöst, und ich halte Kurse von kleiner 0,1 cent für möglich,,, vlt gehen die auch kaputt...

      TRANSCANNA HOLDINGS INC.
      Notes to the Consolidated Financial Statements
      For the year ended November 30, 2018
      7. RELATED PARTY TRANSACTIONS (Continued)
      The performance warrants were valued using the Black-Scholes Option Pricing Model and the following input assumptions:
      Weighted fair value of finders warrants issued $ 0.33
      Risk-free interest rate 1.56%
      Estimated life 3.46 years
      Expected volatility 100%
      Expected dividend yield 0%
      As part of payments for the Royalty Agreement, the Company issued 1,082,473 shares at $0.50 per share to LDS (Note 4) with
      a fair value of $541,237 recognized as research and development expense.
      8. CAPITAL STOCK
      Common Shares
      Authorized: unlimited number of common voting shares without nominal or par value.
      During the year ended November 30, 2018, the Company:
      - issued 2,160,000 common shares at a price of $0.10 per share for proceeds of $216,000.
      - issued 360,000 common shares at a price of $0.25 per share for proceeds of $90,000.
      - issued 1,400,000 units at a price of $0.50 per unit for proceeds of $700,000. Each unit consisted of one common share
      and warrant entitling the holder to purchase one additional common share at a price of $1.00 per share until April 20,
      2020. In connection with these units, the Company issued 125,000 finder’s units with a fair value of $85,246, of
      which $62,500 were recorded as fair value of shares issued.
      - issued 1,082,473 shares at a fair value of $0.50 per share to LDS as part payment for the Royalty Agreement to use the
      track and trace software for a fair value of $541,237 (Note 4).
      - on August 9, 2018, the Company engaged a financial advisor to assist with financing. The advisor will be engaged for
      three months beginning in August and be paid 100,000 shares of the Company’s common stock. In relation, the
      Company issued 100,000 shares at a fair value of $0.50 per share to the advisor as compensation for services, for a
      fair value of $50,000 recorded as consulting expense.
      - on September 25, 2018, the Company engaged a marketing advisor to assist with marketing. The advisor will be
      engaged for two months beginning in September and be paid 25,000 shares of the Company’s common stock. In
      relation, the Company issued 25,000 shares at a fair value of $0.50 per share to the advisor as compensation for
      services, for a fair value of $12,500 recorded as consulting expense.
      - on October 3, 2018, the Company engaged a marketing advisor to assist with marketing. The advisor will be engaged
      for two months beginning in October and be paid 25,000 shares of the Company’s common stock. In relation, the
      Company issued 12,500 shares at a fair value of $0.50 per share to the advisor as compensation for services in
      October for a fair value of $6,250 recorded as consulting expense. In addition, the Company recognized an obligation
      to issue shares for a further 12,500 shares with a fair value of $6,250 in obligation to issue shares, which were issued
      subsequently.
      - on November 1, 2018, the Company engaged a marketing advisor. The advisor will be engaged for two months
      beginning in November and be paid 50,000 shares of the Company’s common stock. The Company recognized an
      obligation to issue shares for 25,000 shares with a fair value of $12,500 in obligation to issue shares, which were
      issued subsequently.
      TRANSCANNA HOLDINGS INC.
      Notes to the Consolidated Financial Statements
      For the year ended November 30, 2018
      8. CAPITAL STOCK (continued)
      Common Shares (continued)
      The finders’ warrants issued as part of the finders’ units were valued using the Black-Scholes Option Pricing Model and
      the following input assumptions:
      Weighted fair value of finders’ warrants issued $ 0.18
      Risk-free interest rate 1.92%
      Estimated life 2 years
      Expected volatility 100%
      Expected dividend yield 0%
      During the period from October 26, 2017 (date of incorporation) to November 30, 2017, the Company:
      - issued 1 share for proceeds of $1 on incorporation, which was subsequently repurchased by the Company.
      - issued 3,000,000 common shares at a price of $0.005 per share for total gross proceeds of $15,000 to related parties.
      The shares issued had a grant date fair value of $0.05 per share, with the resultant difference of $135,000 included in
      share based payments and reserves.
      - issued 3,900,000 common shares at a price of $0.05 per share for total gross proceeds of $195,000.
      Share Purchase Warrants
      As at November 30, 2018, the following share purchase warrants were outstanding:
      Number of Warrants Exercise Price Expiry Date
      660,000 $ 1.00 April 19, 2020
      315,000 $ 1.00 May 1, 2020
      440,000 $ 1.00 May 28, 2020
      110,000 $ 1.00 June 4, 2020
      750,000 $ 0.50 January 9, 2022
      2,275,000 $ 0.84
      The weighted average remaining contractual life of warrants outstanding as of November 30, 2018 was 1.98 years
      9. ADVANCES RECEIVABLE
      On February 23, 2018, the Company signed a promissory note with Flo Distribution, LLC for USD $54,532 (CAD $70,313)
      (“Flo Distro Note”). The principal advanced under the Flo Distro Note had an effective interest rate of 10.47%. It was
      unsecured and matures on October 31, 2018. Interest of USD $2,402 (CAD $2,973) has been accrued on this loan. At
      November 30, 2018, it was determined that the loan was uncollectable and it was impaired due to uncertainty on collectability.
      On April 13, 2018, the Company signed a 90-day promissory note with SuperBad for USD $33,000 (CAD $42,358)
      (“SuperBad Note”). The principal advanced under the SuperBad Note accumulated interest at 10% per annum for an effective
      interest rate of 10.52%. It was unsecured and matured on July 13, 2018. Interest of USD $638 (CAD $825) was accrued on
      the SuperBad Note. In June 2018 TransCanna paid SuperBad to sponsor functions. The cost of these functions totaled USD
      $33,000 and was applied against the principal of the loan. The interest was impaired due to uncertainty on collectability.
      TransCanna Holdings | 0,456 €
      Avatar
      schrieb am 26.08.19 20:39:02
      Beitrag Nr. 2.180 ()
      CURRENT SHARE STRUCTURE ( Angegeben auf der TCan Webside )
      As of April 26 2019 , we had the following share structure:
      Total Shares Outstanding

      31,279,476
      Total Warrants Outstanding

      10,279,093
      Fully Diluted Total Shares & Warrants Outstanding

      42,702,569
      Options

      925,000 Options

      at $.50



      219,000 Options

      at $1.37
      Insider Ownership

      19.3%

      Wenn man sich die tgl. Umsätze anschaut, wird es interessant wie schnell nun der Kurs in den Keller fallen wird,,,,

      Soldaze ist m. Wissens mmt die einzige Marke die TCan hat,, 15 sollen es werden, frag ich mich wie das beazhlt werden soll,,, mit Mios von Aktien die keiner loseisen kann und was passiert mit der leeren Halle nit den 2 oder 3 Verpackungsautomaten .. für Soldaze ? Und wer soll das Zeug kaufen ,,,, da sind viele Fragen offen,,, und man hört in keinster Weise etwas was diese Fa treibt .... könnte stundenlang schreiben, bringt aber nichts ....bin gespannt wie das weitergeht
      TransCanna Holdings | 0,456 €
      • 1
      • 218
      • 689
       Durchsuchen


      Beitrag zu dieser Diskussion schreiben

      TransCannaHoldings auf dem Weg zu einem leader?